产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 25mg | 99% | 询价 | |||
| 50mg | 99% | 询价 | |||
| 100mg | 99% | 询价 | |||
| 250mg | 99% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 25mg | 99% | 询价 | |||
| 50mg | 99% | 询价 | |||
| 100mg | 99% | 询价 | |||
| 250mg | 99% | 询价 |
CAS No. |
1420367-28-7 |
|---|---|
中文名称 |
8-[(3,5-二氟-4-[(6-三氟甲基吡啶-3-基)氧基]苄基)氧基]-1-甲基-1,2,3,4-四氢-6H-嘧啶并[1,6-a]嘧啶-6-酮 |
英文名称 |
8-((3,5-Difluoro-4-((6-(trifluoromethyl)pyridin-3-yl)oxy)benzyl)oxy)-1-methyl-1,2,3,4-tetrahydro-6H-pyrimido[1,6-a]pyrimidin-6-one |
别名 |
Lp-PLA2 inhibitor;GSK 2814338;GSK-2814338;Lp-PLA2 -IN-1;Lp-PLA2 inhibitor 1;Lp-PLA2 -IN-1(GSK2814338);inhibit,Lp-PLA-2-IN-1,LpPLA2IN1,Inhibitor,Lp PLA2 IN 1,Phospholipase;6H-Pyrimido[1,6-a]pyrimidin-6-one, 8-[[3,5-difluoro-4-[[6-(trifluoromethyl)-3-pyridinyl]oxy]phenyl]methoxy]-1,2,3,4-tetrahydro-1-methyl-;8-((3,5-Difluoro-4-((6-(trifluoromethyl)pyridin-3-yl)oxy)benzyl)oxy)-1-methyl-1,2,3,4-tetrahydro-6H-pyrimido[1,6-a]pyrimidin-6-one |
标准英文名 |
8-((3,5-difluoro-4-((6-(trifluoromethyl)pyridin-3-yl)oxy)benzyl)oxy)-1-methyl-1,2,3,4-tetrahydro-6H-pyrimido[1,6-a]pyrimidin-6-one |
分子式 |
C21H17F5N4O3 |
分子量 |
468.38 |
精确分子量 |
468.12 |
SMILES |
O=C1N=C(OCC2=CC(F)=C(OC3=CC=C(C(F)(F)F)N=C3)C(F)=C2)C=C4N(C)CCCN41 |
标准SMILES |
CN1CCCN2C(=O)N=C(C=C21)OCC1C=C(F)C(OC2C=NC(=CC=2)C(F)(F)F)=C(F)C=1 |
性状 |
Powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
QJIGPJZJKXZSNF-UHFFFAOYSA-N |
危险类别(旧) |
H302,H315,H319 |
存储要求 |
Sealed in dry, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|